The largest database of trusted experimental protocols

Pichia easycomp transformation kit

Manufactured by Thermo Fisher Scientific
Sourced in United States

The Pichia EasyComp Transformation kit is a laboratory product designed to facilitate the transformation of Pichia pastoris yeast. The kit provides the necessary components and reagents required to perform the transformation process.

Automatically generated - may contain errors

11 protocols using pichia easycomp transformation kit

1

Production and Assay of Tc-LysN Protease

Check if the same lab product or an alternative is used in the 5 most similar protocols
The native pro-protein gene for Tc-LysN was cloned in-frame with the S. cerevisiae’s α-mating factor secretory signal into pBSY2S1Z, under the control of the methanol-inducible AOX1 promoter, via golden gate cloning (Engler et al. 2008 ) using SapI restriction sites. Chemically competent E. coli DH5α cells were transformed with the resulting expression vector, pBSY2S1Z–Tc-LysN. Isolated recombinant plasmids from single-colony transformants, selected on low salt Luria-Bertani (LB) plates supplemented with 25 μg*mL−1 Zeocin®, were sent for DNA sequencing to Genewiz (Leipzig, Germany).
Komagataella phaffii BG10 transformation was carried out by stringently following the guidelines of Invitrogen’s Pichia EasyComp™ Transformation Kit. In brief, 50 μL chemically competent Komagataella phaffii BG10 cells were transformed using ∼10 μg purified pBSY2S1Z–Tc-LysN that was linearized by SacI-HF (according to NEB’s protocol). Single colonies were screened for enzyme activity after ~24 h of induction in BMMY at 30 °C using the standard method outlined in Invitrogen’s Pichia EasyComp™ Transformation Kit. Tc-LysN activity was analyzed by employing the azocasein assay (“Determination of endopeptidase acting using the azocasein assay” section).
+ Open protocol
+ Expand
2

Pichia Glucoamylase Expression Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pPICZαC_GA carrying the insert was linearized by SacI and transformed into P. pastoris GS115 (Invitrogen) competent cells. The competent cells were prepared by using the Pichia EasyComp Transformation kit according to the instruction guidelines (Invitrogen). Linearized vector pPICZαC, without insert, was also transformed into P. pastoris GS115 and used as a control. After transformation, Pichia cells were plated onto yeast extract peptone dextrose sorbitol (YPDS) agar plate containing 150 μg mL−1 zeocin and incubated for 3 to 8 days at 30°C. Transformed colonies were confirmed by colony PCR using 5′AOX1 and 3′AOX1 primers and glucoamylase gene specific primers. Putative Mut+ colony was selected based on PCR using AXO1 primers. Several Mut+ colonies from YPDS agar plate were selected and independently blotted onto Buffered Methanol-complex Medium (BMMY) (containing 1% (w/v) yeast extract, 2% (w/v) peptone, 1.34% (w/v) YNB, 4 × 10−5% (w/v) biotin, 0.5% (v/v) methanol, and 100 mM potassium phosphate buffer pH 6.0) agar plate containing 1% (w/v) soluble starch. Glucoamylase producing transformants were identified by the formation of decolorization zone or clear halo around the Pichia colonies after the addition of iodine solution.
+ Open protocol
+ Expand
3

Recombinant Irisin Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human recombinant irisin (r‐irisin) was expressed and purified as previously described15. Briefly, human irisin cDNA (360 bp), designed and synthesized by Life Technologies, was cloned into the EcoRI/XbaI sites of the plasmid pPICZaA. According to the protocol provided with the PichiaEasyComp Transformation Kit (Invitrogen, Carlsbad, CA, USA), linearized pPICZaAirisin plasmid was used to transform Pichia pastoris X‐33, following which the yeast cells were cultured and r‐irisin expression was induced and r‐irisin protein in the culture supernatant was purified as described in a previous study (15).
+ Open protocol
+ Expand
4

Recombinant mLTC4S Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression vector was transformed into P. pastoris KM71H cells using the Pichia EasyComp Transformation kit (Invitrogen). The protein was expressed and purified from Pichia pastoris as previously described [15] (link). The purified protein was either stored frozen at –20°C or directly further polished in a buffer exchange step on a Superdex 200 16/60 (GE Healthcare) equilibrated with 0.03% w/v DDM (w/v), 20 mM Tris pH 8.0, 100 mM NaCl and 0.5 mM TCEP. Fractions containing mLTC4S were concentrated to 3.5 mg ml−1 by ultrafiltration and used for setting-up crystallization and activity assays.
+ Open protocol
+ Expand
5

Recombinant Human Irisin Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression and purification of human irisin were performed as previously described [10] (link). Briefly, the cDNA (360 bp) of human irisin was designed and synthesized by Life Technologies. The synthesized human irisin cDNA was cloned into EcoR1/Xba1 sites of the pPICZaA plasmid. A linearized pPICZaA-irisin plasmid was use to transforme the P. pastorisX-33 according to the kit manual (PichiaEasycomp Transformation Kit; Invitrogen). The induction of protein expression and culture of yeast were performed as previously described [10] (link). Then the r-irisin protein in the supernatant was purified and used in our study.
+ Open protocol
+ Expand
6

Generating Zeocin-Resistant Pichia Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate the toxin-expressing strains, each expression plasmid was linearized by digestion with the restriction enzyme SacI at 37 °C overnight and transformed into P. pastoris X-33 competent cells using the Pichia EasyComp Transformation Kit (Invitrogen, United States, Cat. No. K173001) according to the protocol indicated by the manufacturer. The transformed X-33 cells were spread on a YPD agar plate (1% yeast extract, 2% peptone, 2% dextrose, 2% agar, pH 7.0) containing 200 µg/mL Zeocin (Invitrogen, United States, Cat. No. R25005). After 72 h incubation at 30 °C, the 15–25 biggest colonies were grown on YPD plates supplemented with progressively increasing amounts of Zeocin (500, 1000, and 2000 µg/mL) to select the clone that exhibited hyper-resistance to Zeocin. To confirm the integration of the expression construct into the genome of the Pichia transformants, a colony PCR using plasmid and gene-specific primers was performed on colonies grown on 2000 µg/mL Zeocin.
+ Open protocol
+ Expand
7

Zeocin-resistant Pichia pastoris Transformation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression plasmid was linearized by digesting with SacI endonuclease enzyme and transformed into P. pastoris X-33 competent cells using Pichia EasyComp Transformation Kit (Invitrogen, United States), following the protocol specified by the manufacturer. Transformed X-33 cells were spread on YPD agar plate (2% peptone, 1% yeast extract, 2% agar, 2% dextrose, and pH 7.0) containing 100 µg/ml of Zeocin. After 3-day incubation at 28°C, 24 prominent colonies were regrown on YPD plates supplemented with progressively increasing Zeocin 500, 1000, and 2000 µg/ml for the selection of the clone showing hyper-resistance against Zeocin. To confirm the integration of expression construct into the genome of Pichia transformants, survived on 2000 µg/ml Zeocin, colony PCR was performed by using plasmid-specific primers.
+ Open protocol
+ Expand
8

Cloning and Expression of Rat r-sFNDC5

Check if the same lab product or an alternative is used in the 5 most similar protocols
The rat r-sFNDC5 cDNA (167 amino acids) was designed and synthesized and then cloned into the EcoRI/XbaI site of pPICZαA (Invitrogen, USA). The resulting pPICZαA-sFNDC5 plasmid was transformed into Pichia pastoris X-33 competent cells following the manufacturer’s instructions (Pichia Easycomp Transformation Kit, Invitrogen, USA).
+ Open protocol
+ Expand
9

Highly Efficient Pichia pastoris Transformation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Competent P. pastoris KM71 or KM71H cells were prepared using the Pichia.EasyCompTM transformation kit (Invitrogen, CA, United States) and aliquots (50 μl) were stored at −80°C. Transformation was performed following the LiAc/SS-DNA/PEG procedure (Gietz et al., 1995 (link)) using Pichia.Easycomp transformation kit (Invitrogen, CA, United States). Prior to transformation, the pPICZB vectors (Borovsky, 2015 ) were linearized with BstXI to facilitate homologous recombination at the AOX1 promotor locus. Transformants were selected on YPDS plates (1%Yeast Extract, 2% Peptone, 2% Dextrose, 1 M Sorbitol, and 2% Agar) with 100 μg/ml ZeocinTM at 30°C. Transformants selected on 100 μg/ml Zeocin plates were further tested on YPDS plates with increased concentrations of ZeocinTM (200 to 3000 μg/ml). The plates were incubated for several days at 30°C. Colonies that grew on the highest concentrations of Zeocin were selected.
+ Open protocol
+ Expand
10

Production and Purification of Recombinant Irisin

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression and purification of irisin were performed as previously described.9, 28 Briefly, human irisin cDNA (360 bp) was designed, synthesized (Life Technologies), and cloned into the EcoR1/Xba1 sites of the pPICZαA plasmid. The linearized pPICZaA‐irisin plasmid was transformed into Pichia pastoris X‐33 according to the manufacturer's instructions (PichiaEasycomp Transformation Kit; Invitrogen). Yeast culture was used for the production of human irisin protein as previously described.9 The r‐irisin protein in the culture supernatant was purified and used in this study.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!